rs11978015 - SOCS5P1 - GRM3

Magnitude 2.2 · 1 study on file

Reported associations

• Genome-Wide Meta-Analysis Identifies Two Novel Risk Loci for Epilepsy - Unknown journal (n.d.) · Unknown authors · PubMed 34456681

  ABSTRACT: Epilepsy (affects about 70 million people worldwide) is one of the most prevalent brain disorders and imposes a huge economic burden on society. Epilepsy has a strong genetic component. In this study, we perform the largest genome-wide meta-analysis of epilepsy (N = 8,00,869 subjects) by integrating four large-scale genome-wide association studies (GWASs) of epilepsy. We identified three genome-wide significant (GWS) (p < 5 × 10-8) risk loci for epilepsy. The risk loci on 7q21.11 [lead single nucleotide polymorphism (SNP) rs11978015, p = 9.26 × 10-9] and 8p23.1 (lead SNP rs28634186, p = 4.39 × 10-8) are newly identified in the present study. Of note, rs11978015 resides in upstream of GRM3, which encodes glutamate metabotropic receptor 3. GRM3 has pivotal roles in neurotr

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.